摘要
目的 探析病灶切除术后联合左炔诺孕酮宫内缓释系统治疗内突型子宫腺肌瘤的临床价值和使用意义。方法 选择我院2023年2月-2024年2月,一年间收治的30例内突型子宫腺肌瘤患者作为研究对象。将患者按照治疗方法的不同随机分为对照组(15例,使用病灶切除术治疗)和研究组(15例,实施病灶切除术后联合左炔诺孕酮宫内缓释系统治疗)。对两组患者的治疗效果进行收集和分析。结果 两组患者在治疗后均取得一定效果,研究组患者VAS、PBAC评分以及E2、LH、FSH水平均相对于对照组显著更低,差异具有统计学上的显著性(P<0.05)。结论 病灶切除术后联合左炔诺孕酮宫内缓释系统治疗对内突型子宫腺肌瘤患者具备显著的临床效果,能够有效改善患者的月经情况,有较高的应用价值。
关键词: 病灶切除术;左炔诺孕酮宫内缓释系统;子宫腺肌瘤;治疗效果
Abstract
Objective To explore the clinical value and significance of using levonorgestrel intrauterine sustained-release system in the treatment of protruding uterine adenomyoma after lesion resection. Methods Fifty patients with protruding uterine adenomyoma admitted to our hospital from September 2022 to September 2023 were selected as the study subjects. Patients were randomly divided into a control group (25 cases, treated with lesion resection) and a study group (25 cases, treated with lesion resection combined with levonorgestrel intrauterine sustained-release system) according to different treatment methods. Collect and analyze the treatment outcomes of two groups of patients. Results Both groups of patients achieved certain results after treatment. The VAS, PBAC scores, E2, LH, and FSH levels in the study group were significantly lower than those in the control group, and the difference was statistically significant (P<0.05). Conclusion The combined use of levonorgestrel intrauterine sustained-release system after lesion resection has significant clinical effects on patients with protruding uterine adenomyoma, effectively improving their menstrual status, and has high application value.
Key words: Lesion resection surgery; Levonorgestrel intrauterine sustained-release system; Uterine adenomyoma; treatment effect
参考文献 References
[1] 吕梦潇,黄晓燕,武玉蕊,等.子宫腺肌瘤与生育相关问题的研究进展[J].实用妇产科杂志,2021,37(09):664-667.
[2] 王丽丽,沈雪,章宪慧,等.子宫腺肌症的现代医学诊断及治疗[J].中国医学创新,2022,19(25):185-188.
[3] 甘莉.GnRH-a及LUNA在子宫腺肌瘤保守性手术中的应用研究[J].医学理论与实践,2024,37(06):982-984.
[4] 田苑.宫腔镜下病灶切除术对内突型子宫腺肌瘤患者月经量的影响[J].吉林医学,2021,42(09):2250-2252.
[5] 杜洁贤,秦姗,张新景,等.GnRH-a与LNG-IUS联合应用在宫腔镜下内突型子宫腺肌瘤病灶切除术中的价值[J].河北医科大学学报,2019,40(08):902-906.
[6] 李晶,岑瑾,刘启宏.左炔诺孕酮宫内缓释系统联合宫腔镜切除术治疗子宫内膜息肉效果观察[J].中国乡村医药,2022,29(04):9-10.
[7] 张美霞.左炔诺孕酮宫内节育系统结合病灶切除术对子宫腺肌病患者远期疗效的影响[J].当代医学,2020,26(35): 155-157.
[8] 蔡燕聪.腹腔镜下病灶切除联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病的疗效观察[J].大医生,2024,9(02):10-12.